The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

AI-powered Simulation & Digital Twins Market is witnessing rapid growth, with projections indicating a market size of USD 81.3 ...

A low-cost otoacoustic emission probe and smartphone app performed as well as commercially available devices for hearing loss ...

Study highlights concerns about premature adoption of preeclampsia screening tests, emphasizing the need for clinical utility trials before widespread implementation.

Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, recently ...

Study shows combined endobronchial ultrasound and endoscopic ultrasound (CUS) is a highly reliable tool for ruling out N2 ...

Adaptive humor style can help adjust to the social interactions of first-year college students. This study aims to explore ...

The deployment of AI for direct-to-physician ECG reporting has far-reaching implications for healthcare systems worldwide.

Triple-negative breast cancer is a subgroup of breast cancer with scarce targeted treatment options, resulting in a poor ...

Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary ...

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC), a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions ...